Population-based case-control study explores cancer prevalence in myasthenia gravis, suggesting a direct link to the disease.
MG patients have a higher prevalence of both solid and hematologic neoplasms compared to non-myasthenic controls, regardless of immunosuppressive treatment. This supports the notion that malignancy is related to MG disease itself rather than external factors.
No takes yet. Share an insight, caveat, or question.
Pardo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: